Prolonged exposure to deep-space galactic cosmic radiation during a crewed mission to Mars can trigger irreversible cardiac fibrosis and microvascular scarring in heart tissue, substantially increasing the long-term risk of congestive heart failure decades after astronauts return to Earth. This sober warning emerges from an extensive biomedical investigation led by researchers at the Medical College of Wisconsin in collaboration with NASA, published in the peer-reviewed journal PLOS ONE. Utilizing NASA’s Simulated Galactic Cosmic Ray Simulation (SimGCRSim) facility, the study revealed that high-energy galactic cosmic rays selectively attack the heart’s microvascular architecture, doubling the accumulation of rigid scar tissue that impairs the myocardium’s ability to relax during diastole.
Beyond the Geomagnetic Shield: The Hostile Deep-Space Radiation Environment
Human physiology evolved over hundreds of millions of years beneath the protective umbrella of Earth’s biosphere. The planet’s geomagnetic field (magnetosphere) and dense atmospheric envelope deflect and absorb the vast majority of lethal ionizing radiation. All prior extended human spaceflights—from the Mir and Skylab orbital stations to the International Space Station (ISS)—have operated in Low Earth Orbit (LEO) at altitudes around 400 kilometers, where the magnetosphere still provides substantial shielding.

However, an interplanetary voyage to Mars, requiring an estimated 18 to 24-month round trip under current propulsion capabilities, takes spacecraft completely outside this protective envelope. In interplanetary space, crews will confront two major categories of ionizing radiation: sporadic, high-flux Solar Particle Events (SPE) and a persistent, highly penetrating flux of Galactic Cosmic Rays (GCR).
Galactic cosmic rays originate beyond our Solar System, propelled by ancient supernova shockwaves and active galactic nuclei. They consist of high-energy protons and high-charge, high-energy (HZE) atomic nuclei—such as iron, silicon, and carbon—accelerated to near-relativistic velocities. These heavy ions possess immense kinetic energy; standard spacecraft aluminum shielding cannot stop them and paradoxically produces dangerous secondary Bremsstrahlung radiation upon impact.
Brookhaven Simulation: NASA SimGCRSim Chamber in Action
To accurately recreate the radiobiological environment of deep-space transit, Dr. John E. Baker and his colleagues partnered with NASA’s Space Radiation Laboratory (NSRL) at Brookhaven National Laboratory. The experiment deployed NASA’s state-of-the-art Simulated Galactic Cosmic Ray Simulation (SimGCRSim), an advanced accelerator complex capable of rapidly switching between 33 distinct ion and energy combinations to mirror the true cosmic spectrum.
The research team divided Rattus norvegicus subjects into four cohorts to disentangle the respective physiological tolls of space radiation and weightlessness. To simulate microgravity, researchers utilized the standard hindlimb suspension model, which replicates the cephalad fluid shift and muscular unloading experienced during orbital freefall.
While primitive organisms exhibit astonishing resilience—much like how tardigrades employ Dsup proteins to shield their DNA in open vacuum—the delicate cardiovascular architecture of mammalian biology proves far more vulnerable to galactic cosmic rays.

«The core message we are conveying is that long-term health surveillance is paramount for interplanetary explorers. When astronauts return to Earth, society expects them to live long, healthy lives. However, our findings show that microvascular radiation scarring in cardiac tissue could manifest as clinical heart failure twenty to thirty years down the road.»
Dr. John E. Baker, Professor of Surgery at the Radiation Bioscience Laboratory, Medical College of Wisconsin
Anatomy of Microvascular Scarring: Myocardial Fibrosis
When researchers examined cardiac tissue 360 days after radiation exposure, histopathological analysis revealed severe structural remodeling. In subjects exposed to simulated GCR, perivascular scar tissue surrounding myocardial capillaries and arterioles had surged by 100% compared to unexposed controls.
Crucially, animals exposed solely to simulated microgravity without radiation showed no significant increase in myocardial fibrosis. «This confirms that it was specifically galactic radiation, rather than weightlessness, that produced the permanent damaging scar tissue in the heart», Dr. Baker noted. However, microgravity did induce lasting suppression of circulating T-lymphocytes, compromising systemic immune defenses.
Under bombardment by dense HZE ionization tracks, microvascular endothelial cells undergo severe oxidative stress, releasing pro-inflammatory cytokines and transforming growth factor-beta (TGF-beta). This chemical cascade prompts cardiac fibroblasts to deposit excessive quantities of stiff type I and III fibrillar collagen. Encased in a rigid fibrous matrix, the microvasculature loses compliance, stiffening the surrounding myocardium.
High-energy iron and silicon nuclei pierce spacecraft hulls, producing complex clustered double-strand DNA breaks in heart tissue.
At 360 days post-exposure, perivascular connective scar tissue around myocardial arterioles increased by exactly 100%.
Excessive collagen deposition impairs ventricular relaxation during diastole, predisposing astronauts to HFpEF heart failure.
In human timescales, microvascular scarring may remain clinically dormant before triggering cardiac failure decades later.
The Diastolic Trap: When the Heart Cannot Relax
The primary functional hazard of this microvascular fibrosis lies in the impairment of cardiac diastolic relaxation. In healthy cardiovascular physiology, the heart acts as a compliant muscular pump: it contracts vigorously during systole to eject oxygenated blood and relaxes completely during diastole to fill under low venous pressures.
The accumulation of dense collagen around coronary microvessels creates structural rigidity. The heart retains its ability to contract during systole, but it cannot relax properly during diastole (diastolic dysfunction). In clinical cardiology, this pathology corresponds to Heart Failure with Preserved Ejection Fraction (HFpEF)—a notoriously challenging condition that responds poorly to standard cardiovascular medications.
Translating these rodent findings to human lifespans requires accounting for biological time scaling. Laboratory rats live roughly 2 to 4 years, meaning that a 360-day observation window represents nearly a third of their lifespan. In humans, whose average life expectancy approaches 80 years, comparable microvascular radiation damage could remain clinically silent before manifesting as overt congestive heart failure 25 to 30 years after returning from Mars.
- Total Radiation Burden: An 18-month round trip exposes astronauts to approximately 1 Sievert of ionizing cosmic radiation.
- Factor Isolation: Microgravity suppresses immune T-cells, but microvascular cardiac fibrosis is driven solely by radiation.
- NASA SimGCRSim: Groundbreaking accelerator system that realistically replicates the 33-component galactic cosmic ray spectrum.
- Countermeasure Development: Combining hydrogen-rich composite shielding with oral radioprotective antifibrotic medications.
Engineering the Shield: Advanced Spacecraft Materials and Radioprotectants
Commenting on the findings, Dr. Rupak Pathak, an associate professor of pharmaceutical sciences at the University of Arkansas for Medical Sciences who holds a doctorate in radiation biology, emphasized: «While rodents and humans have distinct physiological differences, we share over 90% of genetic information, and our cardiac microvascular systems are structurally very similar. This research presents an urgent engineering and medical mandate».
Humanity’s scientific curiosity continues to explore the cosmic origins of biology—with planetary researchers suggesting that early cometary impacts may have seeded organic precursors on ancient Mars—yet safeguarding astronaut lives requires radical innovation in deep-space protective architecture.
NASA and international space agencies are actively developing multi-layered countermeasures. Aerospace engineers are testing hydrogen-dense polyethylene composites and water-shielded sleeping quarters to attenuate heavy cosmic ions. Concurrently, space pharmacologists are evaluating targeted radioprotective therapies, including TGF-beta inhibitors, angiotensin receptor blockers, and mitochondrial antioxidants designed to arrest the fibrotic cascade at the cellular level before chronic remodeling takes hold.



